CFR section
21 CFR 530.13(a): Extralabel use from compounding of approved new animal and approved human drugs
PART 530-EXTRALABEL DRUG USE IN ANIMALS · Subpart B-Rules and Provisions for Extralabel Uses of Drugs in Animals
Key facts
| Citation | 21 CFR 530.13(a) |
|---|---|
| Section | Extralabel use from compounding of approved new animal and approved human drugs |
| Part | PART 530-EXTRALABEL DRUG USE IN ANIMALS |
| Subpart | Subpart B-Rules and Provisions for Extralabel Uses of Drugs in Animals |
| Subchapter | 21 CFR E Drugs Animal |
| Product types cited | Drugs, Veterinary |
| Regulation text (excerpt) | (a) This part applies to compounding of a product from approved animal or human drugs by a veterinarian or a pharmacist on the order of a veterinarian within the practice of veterinary medicine. Nothing in this part shall be construed as permitting compounding from bulk drugs. |
At a glance
- 10–99 Inspections citing this section
- 1–9 Warning letters citing this section
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About CFR sections cited by the FDA
Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.